Not yet recruitingNCT05406947

Establishment and Clinical Application of Risk Classification Model Based on Molecular Typing of Medulloblastoma in Children

Studying Medulloblastoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Beijing Tiantan Hospital
Principal Investigator
Yongji Tian, MD
Beijing TianTanHospital, China Capital Medical University
Intervention
Prospective observational study, no intervention(other)
Enrollment
350 enrolled
Eligibility
18 years · All sexes
Timeline
2023 – 2030

Collaborators

Beijing Neurosurgical Institute · Beijing Children's Hospital · Beijing Shijitan Hospital, Capital Medical University · Xuanwu Hospital, Beijing · Peking University Third Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05406947 on ClinicalTrials.gov

Other trials for Medulloblastoma

Additional recruiting or active studies for the same condition.

See all trials for Medulloblastoma →

← Back to all trials